About Bolder Science

Our mission is to provide healthcare professionals with unbiased clinical research information, easily.

Currently, you can access the following clinical trials being conducted worldwide:

359,057 studies
in
219 countries
Clinical trial information and results are updated daily from ClinicalTrials.gov. The latest data update was conducted on 01/16/2021.
This website is for US healthcare professionals

Log In to Bolder Science

or

Don't have an account? Sign Up

Please enter your email address.

You will receive a link to create a new password via email.

Log In

Create an Account

or
(optional) ?

Welcome, !

Please complete the following 4 questions to ensure you receive the information that best suits your needs.

Clinical Trials of Interest

When I’m looking for information on clinical trials, I usually am interested in...

finding clinical trials in which to enroll my patients

Rarely Often

finding newly launched clinical trials (for all phases)

Rarely Often

updates on status changes for clinical trials

Rarely Often

pipeline molecules

Rarely Often

Drug Interventions

Enter up to 3 drug interventions you are currently interested in:

Clinical trial information and results are updated daily from ClinicalTrials.gov. The latest data update was conducted on 01/16/2021.

Evaluation of Oral and Maxillofacial Swellings by Ultrasonographic Features

Clinicaltrials.gov identifier NCT03928730

Recruitment Status Recruiting

First Posted April 26, 2019

Last update posted January 29, 2020

Study Description

Brief summary:

Fifty patients were randomly selected with oral and/or maxillofacial swelling, thorough case history and clinical examination were done, then ultrasound examinations were done for all of them and they were classified into five groups (I. inflammatory/space infection and abscess swellings), (II. cystic swellings), (III. lymph node swellings), (IV. benign swellings) and (V. malignant neoplastic swellings) according to their ultrasound features. The patients were subjected to histopathologic evaluation.

  • Condition or Disease:Swelling Lips & Face
  • Intervention/Treatment: Procedure: resection and removal
  • Phase: N/A
Detailed Description

Fifty patients with swellings in the oral and/or maxillofacial region were randomly selected. Any other swellings that were caused by trauma and/or fracture, extended below the neck or patient reluctant to undergo US were excluded from the study. This study was approved by the (Research Ethics Committee) (REC), Faculty of Dentistry, Minia University before starting the research and all the entire patients had signed a standardized informed consent laid down by REC. A comprehensive questionnaire was used to assess history and through extra-oral & intra-oral examinations were carried out and recorded on the basis of criteria reported by Das.11 The ultrasonographic investigations were carried using an ultrasound diagnostic modality (LOGIQ- P5) (GE Medical System, Korea) with color Doppler function by using a linear array transducer, operating at a frequency of (7.5-12 MHz). All the examinations were performed over the swellings and also compared to the contra-lateral/normal side whenever needed. (Fig. 1) All sonographic images were interpreted by an expert sonologist (15 years experience) and US features were recorded to extract ultrasonographic guided (USG) diagnosis and patient's swellings were categorized into five groups: inflammatory/infection/abscess swellings (Group I), cystic swellings (Group II), lymph node swellings (Group III), benign swellings (Group IV) and malignant neoplastic swellings (Group V).12 Finally, the included patients were subjected to either fine needle aspiration cytology (FNAC) or surgical intervention for histopathological examination to extract the histopathological diagnosis

Study Design
  • Study Type: Interventional
  • Estimated Enrollment: 50 participants
  • Allocation: Randomized
  • Intervention Model: Sequential Assignment
  • Masking: None (Open Label) ()
  • Primary Purpose: Diagnostic
  • Official Title: Assessment of Ultrasonographic Examination for Maxillofacial Swellings
  • Actual Study Start Date: January 2020
  • Estimated Primary Completion Date: March 2020
  • Estimated Study Completion Date: April 2020
Arms and interventions
Arm Intervention/treatment
Other: Group I
Inflammatory swellings
Procedure: resection and removal
Surgical resection or removal for histopathological examination
Other: Group II
Cystic swellings
Procedure: resection and removal
Surgical resection or removal for histopathological examination
Other: Group III
Lymph node swellings
Procedure: resection and removal
Surgical resection or removal for histopathological examination
Other: Group IV
Benign swellings
Procedure: resection and removal
Surgical resection or removal for histopathological examination
Other: Group V
Malignant swellings
Procedure: resection and removal
Surgical resection or removal for histopathological examination
Outcome Measures
  • Primary Outcome Measures: 1. Correlation between ultrasonographic features and swellings types [ Time Frame: 2 months ]
    Correlation between ultrasonographic features and swellings types
Eligibility Criteria
  • Ages Eligible for Study: (Child, Adult, Older Adult)
  • Sexes Eligible for Study: All
  • Accepts Healthy Volunteers: No
Criteria

Inclusion Criteria:

- All with oral and/or maxillofacial swelling,

Exclusion Criteria:

- Any other swellings that were caused by trauma and/or fracture, extended below the
neck or patient reluctant to undergo US were excluded from the study.

Contacts and Locations
Contacts

Contact: TAbdallah +201006187539 tarek_dentist2008@yahoo.com

Contact: Maha Eshak, Prof +201005078358 ext Int mahaeshaq2@2yahoo.com

Locations

Egypt
MiniaU
Minya

Sponsors and Collaborators

Tarek Abdallah

More Information
  • Responsible Party: Tarek Abdallah
  • ClinicalTrials.gov Identifier: NCT03928730 History of Changes
  • Other Study ID Numbers: TAbdallah
  • First Posted: April 26, 2019 Key Record Dates
  • Last Update Posted: January 29, 2020
  • Last Verified: January 2020
  • Studies a U.S. FDA-regulated Drug Product: No
  • Studies a U.S. FDA-regulated Device Product: No
  • Product Manufactured in and Exported from the U.S.: Yes